nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Malnutrition—Quinine—malaria	0.00222	0.00222	CcSEcCtD
Gadoversetamide—Nausea—Proguanil—malaria	0.00221	0.00221	CcSEcCtD
Gadoversetamide—Dysgeusia—Clindamycin—malaria	0.00221	0.00221	CcSEcCtD
Gadoversetamide—Vision blurred—Dapsone—malaria	0.0022	0.0022	CcSEcCtD
Gadoversetamide—Back pain—Clindamycin—malaria	0.00218	0.00218	CcSEcCtD
Gadoversetamide—Erythema multiforme—Quinidine barbiturate—malaria	0.00217	0.00217	CcSEcCtD
Gadoversetamide—Muscle spasms—Clindamycin—malaria	0.00217	0.00217	CcSEcCtD
Gadoversetamide—Decreased appetite—Sulfadiazine—malaria	0.00215	0.00215	CcSEcCtD
Gadoversetamide—Eye disorder—Quinidine barbiturate—malaria	0.00215	0.00215	CcSEcCtD
Gadoversetamide—Tinnitus—Quinidine barbiturate—malaria	0.00214	0.00214	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Sulfadiazine—malaria	0.00214	0.00214	CcSEcCtD
Gadoversetamide—Cardiac disorder—Quinidine barbiturate—malaria	0.00213	0.00213	CcSEcCtD
Gadoversetamide—Flushing—Quinidine barbiturate—malaria	0.00213	0.00213	CcSEcCtD
Gadoversetamide—Flushing—Pentoxifylline—malaria	0.00213	0.00213	CcSEcCtD
Gadoversetamide—Vertigo—Dapsone—malaria	0.0021	0.0021	CcSEcCtD
Gadoversetamide—Vision blurred—Quinine—malaria	0.00209	0.00209	CcSEcCtD
Gadoversetamide—Vision blurred—Quinidine—malaria	0.00209	0.00209	CcSEcCtD
Gadoversetamide—Tremor—Quinine—malaria	0.00208	0.00208	CcSEcCtD
Gadoversetamide—Tremor—Quinidine—malaria	0.00208	0.00208	CcSEcCtD
Gadoversetamide—Immune system disorder—Quinidine barbiturate—malaria	0.00207	0.00207	CcSEcCtD
Gadoversetamide—Immune system disorder—Pentoxifylline—malaria	0.00207	0.00207	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Quinidine barbiturate—malaria	0.00207	0.00207	CcSEcCtD
Gadoversetamide—Chills—Quinidine barbiturate—malaria	0.00206	0.00206	CcSEcCtD
Gadoversetamide—Arrhythmia—Pentoxifylline—malaria	0.00205	0.00205	CcSEcCtD
Gadoversetamide—Cough—Dapsone—malaria	0.00204	0.00204	CcSEcCtD
Gadoversetamide—Agitation—Quinidine—malaria	0.00204	0.00204	CcSEcCtD
Gadoversetamide—Agitation—Quinine—malaria	0.00204	0.00204	CcSEcCtD
Gadoversetamide—Vertigo—Clindamycin—malaria	0.00203	0.00203	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Sulfadiazine—malaria	0.00202	0.00202	CcSEcCtD
Gadoversetamide—Mental disorder—Quinidine barbiturate—malaria	0.00201	0.00201	CcSEcCtD
Gadoversetamide—Malnutrition—Quinidine barbiturate—malaria	0.002	0.002	CcSEcCtD
Gadoversetamide—Erythema—Quinidine barbiturate—malaria	0.002	0.002	CcSEcCtD
Gadoversetamide—Erythema—Pentoxifylline—malaria	0.002	0.002	CcSEcCtD
Gadoversetamide—Vertigo—Quinine—malaria	0.00199	0.00199	CcSEcCtD
Gadoversetamide—Vertigo—Quinidine—malaria	0.00199	0.00199	CcSEcCtD
Gadoversetamide—Syncope—Quinidine—malaria	0.00199	0.00199	CcSEcCtD
Gadoversetamide—Syncope—Quinine—malaria	0.00199	0.00199	CcSEcCtD
Gadoversetamide—Flatulence—Pentoxifylline—malaria	0.00197	0.00197	CcSEcCtD
Gadoversetamide—Urticaria—Sulfadiazine—malaria	0.00197	0.00197	CcSEcCtD
Gadoversetamide—Tension—Quinidine barbiturate—malaria	0.00196	0.00196	CcSEcCtD
Gadoversetamide—Tension—Pentoxifylline—malaria	0.00196	0.00196	CcSEcCtD
Gadoversetamide—Palpitations—Quinidine—malaria	0.00196	0.00196	CcSEcCtD
Gadoversetamide—Palpitations—Quinine—malaria	0.00196	0.00196	CcSEcCtD
Gadoversetamide—Body temperature increased—Sulfadiazine—malaria	0.00196	0.00196	CcSEcCtD
Gadoversetamide—Abdominal pain—Sulfadiazine—malaria	0.00196	0.00196	CcSEcCtD
Gadoversetamide—Dysgeusia—Pentoxifylline—malaria	0.00195	0.00195	CcSEcCtD
Gadoversetamide—Hypertension—Clindamycin—malaria	0.00195	0.00195	CcSEcCtD
Gadoversetamide—Loss of consciousness—Quinidine—malaria	0.00195	0.00195	CcSEcCtD
Gadoversetamide—Loss of consciousness—Quinine—malaria	0.00195	0.00195	CcSEcCtD
Gadoversetamide—Nervousness—Quinidine barbiturate—malaria	0.00194	0.00194	CcSEcCtD
Gadoversetamide—Nervousness—Pentoxifylline—malaria	0.00194	0.00194	CcSEcCtD
Gadoversetamide—Back pain—Pentoxifylline—malaria	0.00193	0.00193	CcSEcCtD
Gadoversetamide—Convulsion—Quinidine—malaria	0.00192	0.00192	CcSEcCtD
Gadoversetamide—Convulsion—Quinine—malaria	0.00192	0.00192	CcSEcCtD
Gadoversetamide—Muscle spasms—Pentoxifylline—malaria	0.00192	0.00192	CcSEcCtD
Gadoversetamide—Discomfort—Clindamycin—malaria	0.0019	0.0019	CcSEcCtD
Gadoversetamide—Chest pain—Quinidine—malaria	0.00189	0.00189	CcSEcCtD
Gadoversetamide—Myalgia—Quinidine—malaria	0.00189	0.00189	CcSEcCtD
Gadoversetamide—Chest pain—Quinine—malaria	0.00189	0.00189	CcSEcCtD
Gadoversetamide—Myalgia—Quinine—malaria	0.00189	0.00189	CcSEcCtD
Gadoversetamide—Vision blurred—Quinidine barbiturate—malaria	0.00188	0.00188	CcSEcCtD
Gadoversetamide—Vision blurred—Pentoxifylline—malaria	0.00188	0.00188	CcSEcCtD
Gadoversetamide—Tremor—Quinidine barbiturate—malaria	0.00187	0.00187	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.00187	0.00187	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.00187	0.00187	CcSEcCtD
Gadoversetamide—Tremor—Pentoxifylline—malaria	0.00187	0.00187	CcSEcCtD
Gadoversetamide—Tachycardia—Dapsone—malaria	0.00186	0.00186	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Pentoxifylline—malaria	0.00185	0.00185	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Clindamycin—malaria	0.00184	0.00184	CcSEcCtD
Gadoversetamide—Agitation—Quinidine barbiturate—malaria	0.00184	0.00184	CcSEcCtD
Gadoversetamide—Agitation—Pentoxifylline—malaria	0.00183	0.00183	CcSEcCtD
Gadoversetamide—Hypersensitivity—Sulfadiazine—malaria	0.00182	0.00182	CcSEcCtD
Gadoversetamide—Confusional state—Quinine—malaria	0.00182	0.00182	CcSEcCtD
Gadoversetamide—Confusional state—Quinidine—malaria	0.00182	0.00182	CcSEcCtD
Gadoversetamide—Oedema—Quinidine—malaria	0.00181	0.00181	CcSEcCtD
Gadoversetamide—Oedema—Quinine—malaria	0.00181	0.00181	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Clindamycin—malaria	0.0018	0.0018	CcSEcCtD
Gadoversetamide—Malaise—Pentoxifylline—malaria	0.0018	0.0018	CcSEcCtD
Gadoversetamide—Vertigo—Quinidine barbiturate—malaria	0.0018	0.0018	CcSEcCtD
Gadoversetamide—Syncope—Quinidine barbiturate—malaria	0.00179	0.00179	CcSEcCtD
Gadoversetamide—Shock—Quinidine—malaria	0.00178	0.00178	CcSEcCtD
Gadoversetamide—Shock—Quinine—malaria	0.00178	0.00178	CcSEcCtD
Gadoversetamide—Nervous system disorder—Quinidine—malaria	0.00177	0.00177	CcSEcCtD
Gadoversetamide—Nervous system disorder—Quinine—malaria	0.00177	0.00177	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Quinine—malaria	0.00177	0.00177	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Quinidine—malaria	0.00177	0.00177	CcSEcCtD
Gadoversetamide—Palpitations—Quinidine barbiturate—malaria	0.00177	0.00177	CcSEcCtD
Gadoversetamide—Tachycardia—Quinidine—malaria	0.00176	0.00176	CcSEcCtD
Gadoversetamide—Tachycardia—Quinine—malaria	0.00176	0.00176	CcSEcCtD
Gadoversetamide—Palpitations—Pentoxifylline—malaria	0.00176	0.00176	CcSEcCtD
Gadoversetamide—Loss of consciousness—Quinidine barbiturate—malaria	0.00176	0.00176	CcSEcCtD
Gadoversetamide—Skin disorder—Quinine—malaria	0.00176	0.00176	CcSEcCtD
Gadoversetamide—Skin disorder—Quinidine—malaria	0.00176	0.00176	CcSEcCtD
Gadoversetamide—Pruritus—Sulfadiazine—malaria	0.00175	0.00175	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Quinidine—malaria	0.00175	0.00175	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Quinine—malaria	0.00175	0.00175	CcSEcCtD
Gadoversetamide—Convulsion—Quinidine barbiturate—malaria	0.00173	0.00173	CcSEcCtD
Gadoversetamide—Convulsion—Pentoxifylline—malaria	0.00173	0.00173	CcSEcCtD
Gadoversetamide—Anorexia—Quinidine—malaria	0.00172	0.00172	CcSEcCtD
Gadoversetamide—Anorexia—Quinine—malaria	0.00172	0.00172	CcSEcCtD
Gadoversetamide—Insomnia—Dapsone—malaria	0.00172	0.00172	CcSEcCtD
Gadoversetamide—Hypertension—Pentoxifylline—malaria	0.00172	0.00172	CcSEcCtD
Gadoversetamide—Hypotension—Clindamycin—malaria	0.00172	0.00172	CcSEcCtD
Gadoversetamide—Myalgia—Quinidine barbiturate—malaria	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Chest pain—Quinidine barbiturate—malaria	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Arthralgia—Quinidine barbiturate—malaria	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Myalgia—Pentoxifylline—malaria	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Chest pain—Pentoxifylline—malaria	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Anxiety—Quinidine barbiturate—malaria	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Diarrhoea—Sulfadiazine—malaria	0.00169	0.00169	CcSEcCtD
Gadoversetamide—Anxiety—Pentoxifylline—malaria	0.00169	0.00169	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.00169	0.00169	CcSEcCtD
Gadoversetamide—Hypotension—Quinine—malaria	0.00169	0.00169	CcSEcCtD
Gadoversetamide—Hypotension—Quinidine—malaria	0.00169	0.00169	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.00169	0.00169	CcSEcCtD
Gadoversetamide—Discomfort—Pentoxifylline—malaria	0.00168	0.00168	CcSEcCtD
Gadoversetamide—Dry mouth—Pentoxifylline—malaria	0.00166	0.00166	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Quinidine—malaria	0.00165	0.00165	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Quinine—malaria	0.00165	0.00165	CcSEcCtD
Gadoversetamide—Confusional state—Quinidine barbiturate—malaria	0.00165	0.00165	CcSEcCtD
Gadoversetamide—Dyspnoea—Clindamycin—malaria	0.00164	0.00164	CcSEcCtD
Gadoversetamide—Confusional state—Pentoxifylline—malaria	0.00164	0.00164	CcSEcCtD
Gadoversetamide—Oedema—Quinidine barbiturate—malaria	0.00163	0.00163	CcSEcCtD
Gadoversetamide—Oedema—Pentoxifylline—malaria	0.00163	0.00163	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Pentoxifylline—malaria	0.00163	0.00163	CcSEcCtD
Gadoversetamide—Dyspepsia—Clindamycin—malaria	0.00162	0.00162	CcSEcCtD
Gadoversetamide—Dyspnoea—Quinidine—malaria	0.00161	0.00161	CcSEcCtD
Gadoversetamide—Dyspnoea—Quinine—malaria	0.00161	0.00161	CcSEcCtD
Gadoversetamide—Shock—Quinidine barbiturate—malaria	0.00161	0.00161	CcSEcCtD
Gadoversetamide—Shock—Pentoxifylline—malaria	0.0016	0.0016	CcSEcCtD
Gadoversetamide—Nervous system disorder—Quinidine barbiturate—malaria	0.0016	0.0016	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Quinidine barbiturate—malaria	0.0016	0.0016	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Pentoxifylline—malaria	0.00159	0.00159	CcSEcCtD
Gadoversetamide—Tachycardia—Quinidine barbiturate—malaria	0.00159	0.00159	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Clindamycin—malaria	0.00159	0.00159	CcSEcCtD
Gadoversetamide—Tachycardia—Pentoxifylline—malaria	0.00159	0.00159	CcSEcCtD
Gadoversetamide—Fatigue—Clindamycin—malaria	0.00159	0.00159	CcSEcCtD
Gadoversetamide—Skin disorder—Quinidine barbiturate—malaria	0.00158	0.00158	CcSEcCtD
Gadoversetamide—Skin disorder—Pentoxifylline—malaria	0.00158	0.00158	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Quinidine barbiturate—malaria	0.00158	0.00158	CcSEcCtD
Gadoversetamide—Constipation—Clindamycin—malaria	0.00158	0.00158	CcSEcCtD
Gadoversetamide—Pain—Clindamycin—malaria	0.00158	0.00158	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Pentoxifylline—malaria	0.00157	0.00157	CcSEcCtD
Gadoversetamide—Vomiting—Sulfadiazine—malaria	0.00157	0.00157	CcSEcCtD
Gadoversetamide—Decreased appetite—Quinidine—malaria	0.00157	0.00157	CcSEcCtD
Gadoversetamide—Decreased appetite—Quinine—malaria	0.00157	0.00157	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Quinidine—malaria	0.00156	0.00156	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Quinine—malaria	0.00156	0.00156	CcSEcCtD
Gadoversetamide—Rash—Sulfadiazine—malaria	0.00156	0.00156	CcSEcCtD
Gadoversetamide—Dermatitis—Sulfadiazine—malaria	0.00156	0.00156	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Dapsone—malaria	0.00156	0.00156	CcSEcCtD
Gadoversetamide—Anorexia—Quinidine barbiturate—malaria	0.00156	0.00156	CcSEcCtD
Gadoversetamide—Anorexia—Pentoxifylline—malaria	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Headache—Sulfadiazine—malaria	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Hypotension—Quinidine barbiturate—malaria	0.00152	0.00152	CcSEcCtD
Gadoversetamide—Hypotension—Pentoxifylline—malaria	0.00152	0.00152	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Clindamycin—malaria	0.00151	0.00151	CcSEcCtD
Gadoversetamide—Abdominal pain—Dapsone—malaria	0.00151	0.00151	CcSEcCtD
Gadoversetamide—Body temperature increased—Dapsone—malaria	0.00151	0.00151	CcSEcCtD
Gadoversetamide—Feeling abnormal—Quinidine—malaria	0.00149	0.00149	CcSEcCtD
Gadoversetamide—Feeling abnormal—Quinine—malaria	0.00149	0.00149	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.00149	0.00149	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Pentoxifylline—malaria	0.00148	0.00148	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Quinidine—malaria	0.00148	0.00148	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Quinine—malaria	0.00148	0.00148	CcSEcCtD
Gadoversetamide—Insomnia—Pentoxifylline—malaria	0.00147	0.00147	CcSEcCtD
Gadoversetamide—Nausea—Sulfadiazine—malaria	0.00147	0.00147	CcSEcCtD
Gadoversetamide—Urticaria—Clindamycin—malaria	0.00146	0.00146	CcSEcCtD
Gadoversetamide—Body temperature increased—Clindamycin—malaria	0.00146	0.00146	CcSEcCtD
Gadoversetamide—Abdominal pain—Clindamycin—malaria	0.00146	0.00146	CcSEcCtD
Gadoversetamide—Dyspnoea—Quinidine barbiturate—malaria	0.00145	0.00145	CcSEcCtD
Gadoversetamide—Dyspnoea—Pentoxifylline—malaria	0.00145	0.00145	CcSEcCtD
Gadoversetamide—Somnolence—Quinidine barbiturate—malaria	0.00145	0.00145	CcSEcCtD
Gadoversetamide—Somnolence—Pentoxifylline—malaria	0.00145	0.00145	CcSEcCtD
Gadoversetamide—Urticaria—Quinidine—malaria	0.00144	0.00144	CcSEcCtD
Gadoversetamide—Urticaria—Quinine—malaria	0.00144	0.00144	CcSEcCtD
Gadoversetamide—Dyspepsia—Pentoxifylline—malaria	0.00143	0.00143	CcSEcCtD
Gadoversetamide—Body temperature increased—Quinidine—malaria	0.00143	0.00143	CcSEcCtD
Gadoversetamide—Abdominal pain—Quinidine—malaria	0.00143	0.00143	CcSEcCtD
Gadoversetamide—Abdominal pain—Quinine—malaria	0.00143	0.00143	CcSEcCtD
Gadoversetamide—Body temperature increased—Quinine—malaria	0.00143	0.00143	CcSEcCtD
Gadoversetamide—Decreased appetite—Quinidine barbiturate—malaria	0.00142	0.00142	CcSEcCtD
Gadoversetamide—Decreased appetite—Pentoxifylline—malaria	0.00142	0.00142	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.00141	0.00141	CcSEcCtD
Gadoversetamide—Constipation—Quinidine barbiturate—malaria	0.0014	0.0014	CcSEcCtD
Gadoversetamide—Pain—Quinidine barbiturate—malaria	0.0014	0.0014	CcSEcCtD
Gadoversetamide—Constipation—Pentoxifylline—malaria	0.00139	0.00139	CcSEcCtD
Gadoversetamide—Hypersensitivity—Clindamycin—malaria	0.00136	0.00136	CcSEcCtD
Gadoversetamide—Feeling abnormal—Quinidine barbiturate—malaria	0.00134	0.00134	CcSEcCtD
Gadoversetamide—Feeling abnormal—Pentoxifylline—malaria	0.00134	0.00134	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Quinidine barbiturate—malaria	0.00133	0.00133	CcSEcCtD
Gadoversetamide—Hypersensitivity—Quinidine—malaria	0.00133	0.00133	CcSEcCtD
Gadoversetamide—Hypersensitivity—Quinine—malaria	0.00133	0.00133	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Pentoxifylline—malaria	0.00133	0.00133	CcSEcCtD
Gadoversetamide—Asthenia—Clindamycin—malaria	0.00132	0.00132	CcSEcCtD
Gadoversetamide—Pruritus—Clindamycin—malaria	0.0013	0.0013	CcSEcCtD
Gadoversetamide—Asthenia—Quinidine—malaria	0.0013	0.0013	CcSEcCtD
Gadoversetamide—Asthenia—Quinine—malaria	0.0013	0.0013	CcSEcCtD
Gadoversetamide—Urticaria—Quinidine barbiturate—malaria	0.0013	0.0013	CcSEcCtD
Gadoversetamide—Urticaria—Pentoxifylline—malaria	0.00129	0.00129	CcSEcCtD
Gadoversetamide—Abdominal pain—Quinidine barbiturate—malaria	0.00129	0.00129	CcSEcCtD
Gadoversetamide—Body temperature increased—Quinidine barbiturate—malaria	0.00129	0.00129	CcSEcCtD
Gadoversetamide—Abdominal pain—Pentoxifylline—malaria	0.00129	0.00129	CcSEcCtD
Gadoversetamide—Body temperature increased—Pentoxifylline—malaria	0.00129	0.00129	CcSEcCtD
Gadoversetamide—Pruritus—Quinidine—malaria	0.00128	0.00128	CcSEcCtD
Gadoversetamide—Pruritus—Quinine—malaria	0.00128	0.00128	CcSEcCtD
Gadoversetamide—Diarrhoea—Clindamycin—malaria	0.00126	0.00126	CcSEcCtD
Gadoversetamide—Diarrhoea—Quinine—malaria	0.00124	0.00124	CcSEcCtD
Gadoversetamide—Diarrhoea—Quinidine—malaria	0.00124	0.00124	CcSEcCtD
Gadoversetamide—Dizziness—Clindamycin—malaria	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Vomiting—Dapsone—malaria	0.00121	0.00121	CcSEcCtD
Gadoversetamide—Hypersensitivity—Quinidine barbiturate—malaria	0.0012	0.0012	CcSEcCtD
Gadoversetamide—Hypersensitivity—Pentoxifylline—malaria	0.0012	0.0012	CcSEcCtD
Gadoversetamide—Dizziness—Quinidine—malaria	0.0012	0.0012	CcSEcCtD
Gadoversetamide—Dizziness—Quinine—malaria	0.0012	0.0012	CcSEcCtD
Gadoversetamide—Headache—Dapsone—malaria	0.00119	0.00119	CcSEcCtD
Gadoversetamide—Vomiting—Clindamycin—malaria	0.00117	0.00117	CcSEcCtD
Gadoversetamide—Asthenia—Quinidine barbiturate—malaria	0.00117	0.00117	CcSEcCtD
Gadoversetamide—Asthenia—Pentoxifylline—malaria	0.00117	0.00117	CcSEcCtD
Gadoversetamide—Rash—Clindamycin—malaria	0.00116	0.00116	CcSEcCtD
Gadoversetamide—Dermatitis—Clindamycin—malaria	0.00116	0.00116	CcSEcCtD
Gadoversetamide—Headache—Clindamycin—malaria	0.00115	0.00115	CcSEcCtD
Gadoversetamide—Pruritus—Quinidine barbiturate—malaria	0.00115	0.00115	CcSEcCtD
Gadoversetamide—Pruritus—Pentoxifylline—malaria	0.00115	0.00115	CcSEcCtD
Gadoversetamide—Vomiting—Quinidine—malaria	0.00115	0.00115	CcSEcCtD
Gadoversetamide—Vomiting—Quinine—malaria	0.00115	0.00115	CcSEcCtD
Gadoversetamide—Rash—Quinidine—malaria	0.00114	0.00114	CcSEcCtD
Gadoversetamide—Rash—Quinine—malaria	0.00114	0.00114	CcSEcCtD
Gadoversetamide—Dermatitis—Quinidine—malaria	0.00114	0.00114	CcSEcCtD
Gadoversetamide—Dermatitis—Quinine—malaria	0.00114	0.00114	CcSEcCtD
Gadoversetamide—Headache—Quinine—malaria	0.00113	0.00113	CcSEcCtD
Gadoversetamide—Headache—Quinidine—malaria	0.00113	0.00113	CcSEcCtD
Gadoversetamide—Nausea—Dapsone—malaria	0.00113	0.00113	CcSEcCtD
Gadoversetamide—Diarrhoea—Quinidine barbiturate—malaria	0.00112	0.00112	CcSEcCtD
Gadoversetamide—Diarrhoea—Pentoxifylline—malaria	0.00111	0.00111	CcSEcCtD
Gadoversetamide—Nausea—Clindamycin—malaria	0.00109	0.00109	CcSEcCtD
Gadoversetamide—Dizziness—Quinidine barbiturate—malaria	0.00108	0.00108	CcSEcCtD
Gadoversetamide—Dizziness—Pentoxifylline—malaria	0.00108	0.00108	CcSEcCtD
Gadoversetamide—Nausea—Quinidine—malaria	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Nausea—Quinine—malaria	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Vomiting—Quinidine barbiturate—malaria	0.00104	0.00104	CcSEcCtD
Gadoversetamide—Vomiting—Pentoxifylline—malaria	0.00104	0.00104	CcSEcCtD
Gadoversetamide—Rash—Quinidine barbiturate—malaria	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Dermatitis—Quinidine barbiturate—malaria	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Rash—Pentoxifylline—malaria	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Dermatitis—Pentoxifylline—malaria	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Headache—Quinidine barbiturate—malaria	0.00102	0.00102	CcSEcCtD
Gadoversetamide—Headache—Pentoxifylline—malaria	0.00102	0.00102	CcSEcCtD
Gadoversetamide—Nausea—Quinidine barbiturate—malaria	0.000969	0.000969	CcSEcCtD
Gadoversetamide—Nausea—Pentoxifylline—malaria	0.000967	0.000967	CcSEcCtD
